Evaluation of polyneuropathy

References

Key articles

de Greef BTA, Hoeijmakers JGJ, Gorissen-Brouwers CML, et al. Associated conditions in small fiber neuropathy - a large cohort study and review of the literature. Eur J Neurol. 2018 Feb;25(2):348-55.Full text  Abstract

Gwathmey KG, Pearson KT. Diagnosis and management of sensory polyneuropathy. BMJ. 2019 May 8;365:l1108.Full text  Abstract

Reference articles

1. Italian General Practitioner Study Group (IGPSG). Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions. I. Prevalence and general characteristics of the sample. Neurology. 1995;45:1832-1836. Abstract

2. Bharucha NE, Bharucha AE, Bharucha EP. Prevalence of peripheral neuropathy in the Parsi community of Bombay. Neurology. 1991;41:1315-1317. Abstract

3. Savettieri G, Rocca WA, Salemi G, Meneghini F, et al. Prevalence of diabetic neuropathy with somatic symptoms: a door-to-door survey in two Sicilian municipalities. Sicilian Neuro-Epidemiologic Study (SNES) Group. Neurology. 1993;43:1115-1120. Abstract

4. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993 Apr;43(4):817-24. Abstract

5. Simpson DM, Kitch D, Evans SR et al. HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology. 2006;66:1679-1687. Abstract

6. Oaklander AL, Nolano M. Scientific advances in and clinical spproaches to small-fiber polyneuropathy: A review. JAMA Neurol. 2019;76(10):1240–51Full text  Abstract

7. Devigili G, Rinaldo S, Lombardi R, et al. Diagnostic criteria for small fibre neuropathy in clinical practice and research. Brain. 2019 Dec 1;142(12):3728-36.Full text  Abstract

8. Gondim FAA, Barreira AA, Claudino R, et al. Definition and diagnosis of small fiber neuropathy: consensus from the Peripheral Neuropathy Scientific Department of the Brazilian Academy of Neurology. Arq Neuropsiquiatr. 2018 Mar;76(3):200-8.Full text  Abstract

9. de Greef BTA, Hoeijmakers JGJ, Gorissen-Brouwers CML, et al. Associated conditions in small fiber neuropathy - a large cohort study and review of the literature. Eur J Neurol. 2018 Feb;25(2):348-55.Full text  Abstract

10. Novella SP, Inzucchi SE, Goldstein JM: The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve. 2001;24:1229-1231. Abstract

11. Singleton JR, Smith AG, Bromberg MB. Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve. 2001;24:1225-1228. Abstract

12. Tagliati M, Grinnel J, Godbold J, et al. Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings. Arch Neurol. 1999;56:84-89.Full text  Abstract

13. Childs EA, Lyles RH, Selnes OA, et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology. 1999;52:607-613. Abstract

14. Kullberg BJ, Vrijmoeth HD, van de Schoor F, et al. Lyme borreliosis: diagnosis and management. BMJ. 2020 May 26;369:m1041.Full text  Abstract

15. Logina I, Donaghy M. Diphtheritic polyneuropathy: a clinical study and comparison with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 1999 Oct;67(4):433-8.Full text  Abstract

16. Wakerley BR, Yuki N. Mimics and chameleons in Guillain-Barré and Miller Fisher syndromes. Pract Neurol. 2015 Apr;15(2):90-9.Full text  Abstract

17. Gwathmey KG, Pearson KT. Diagnosis and management of sensory polyneuropathy. BMJ. 2019 May 8;365:l1108.Full text  Abstract

18. Thawani SP, Brannagan TH 3rd, Lebwohl B, et al. Risk of Neuropathy Among 28,232 Patients With Biopsy-Verified Celiac Disease. JAMA Neurol. 2015 Jul;72(7):806-11.Full text  Abstract

19. Zis P, Sarrigiannis PG, Rao DG, et al. Gluten neuropathy: prevalence of neuropathic pain and the role of gluten-free diet. J Neurol. 2018 Oct;265(10):2231-2236.Full text  Abstract

20. Notermans NC, Wokke JHJ, Lokhorst HM, et al. Polyneuropathy associated with monoclonal gammopathy of undetermined significance. Brain. 1994;117:1385-1393. Abstract

21. Camdessanché JP, Antoine JC, Honnorat J, et al. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients. Brain. 2002 Jan;125(pt 1):166-75.Full text  Abstract

22. Sukumar N, Saravanan P. Investigating vitamin B12 deficiency. BMJ. 2019 May 10;365:l1865.Full text  Abstract

23. Mazokopakis EE, Starakis IK. Recommendations for diagnosis and management of metformin-induced vitamin B12 (Cbl) deficiency. Diabetes Res Clin Pract. 2012 Sep;97(3):359-67.Full text  Abstract

24. Jung SB, Nagaraja V, Kapur A, et al. Association between vitamin B12 deficiency and long-term use of acid-lowering agents: a systematic review and meta-analysis. Intern Med J. 2015 Apr;45(4):409-16.Full text  Abstract

25. Linnebank M, Moskau S, Semmler A, et al. Antiepileptic drugs interact with folate and vitamin B12 serum levels. Ann Neurol. 2011 Feb;69(2):352-9.Full text  Abstract

26. Owczarek D, Rodacki T, Domagała-Rodacka R, et al. Diet and nutritional factors in inflammatory bowel diseases. World J Gastroenterol. 2016 Jan 21;22(3):895-905.Full text  Abstract

27. European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. 2018 [internet publication].Full text

28. Morales D, Pacurariu A, Slattery J, et al. Association between peripheral neuropathy and exposure to oral fluoroquinolone or amoxicillin-clavulanate therapy. JAMA Neurol. 2019 Jul 1;76(7):827-33.Full text  Abstract

29. Gertz MA, Mauermann ML, Grogan M, et al. Advances in the treatment of hereditary transthyretin amyloidosis: A review. Brain Behav. 2019 Sep;9(9):e01371.Full text  Abstract

30. Lawn ND, Fletcher DD, Henderson RD, et al. Anticipating mechanical ventilation in Guillain-Barré syndrome. Arch Neurol. 2001 Jun;58(6):893-8.Full text  Abstract

31. Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic neuropathy: A position statement by the American Diabetes Association. Diabetes Care. 2017 Jan;40(1):136-54.Full text  Abstract

32. Kwok T, Ting PT, Wong EK, et al. Peripheral neuropathy for dermatologists: what if not diabetic neuropathy? J Cutan Med Surg. 2013 Oct;17 Suppl 1:S1-5.Full text  Abstract

33. National Institute for Health and Care Excellence. Neuropad for detecting preclinical diabetic peripheral neuropathy. Sep 2018 [internet publication].Full text

34. Dros J, Wewerinke A, Bindels PJ, et al. Accuracy of monofilament testing to diagnose peripheral neuropathy: a systematic review. Ann Fam Med. 2009 Nov-Dec;7(6):555-8.Full text  Abstract

35. Rosenberg NR, Portegies P, de Visser M, et al. Diagnostic investigation of patients with chronic polyneuropathy: evaluation of a clinical guideline. J Neurol Neurosurg Psychiatry. 2001;71:205-209.Full text  Abstract

36. England JD, Gronseth GS, Franklin G, et al; American Academy of Neurology. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009;72:185-192. Abstract

37. Hughes RA. Peripheral neuropathy. BMJ. 2002;324:466-469.Full text  Abstract

38. Lang M, Treister R, Oaklander AL. Diagnostic value of blood tests for occult causes of initially idiopathic small-fiber polyneuropathy. J Neurol. 2016 Dec;263(12):2515-27.Full text  Abstract

39. Berenson JR, Anderson KC, Audell RA, et al. Monoclonal gammopathy of undetermined significance: a consensus statement. Br J Haematol. 2010 Jul;150(1):28-38.Full text  Abstract

40. England JD, Gronseth GS, Franklin G, et al; American Academy ofNeurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation. Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Muscle Nerve. 2009;39:116-125. Abstract

41. England JD, Gronseth GS, Franklin G, et al; American Academy of Neurology. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009 (reaffirmed Jan 2019);72:177-184. Abstract

42. England JD, Asbury AK. Peripheral neuropathy. Lancet. 2004 Jun 26;363(9427):2151-61. Abstract

43. American Diabetes Association. Position statement: diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27:S5-S10.Full text  Abstract

44. Mindel A, Tenant-Flowers M. ABC of AIDS: Natural history and management of early HIV infection. BMJ. 2001;322:1290-1293.Full text  Abstract

45. Vitali C, Moutsopoulos HM, Bombardieri S. The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Oral involvement in Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjogren's syndrome. Ann Rheum Dis. 1994;53;637-647.Full text  Abstract

46. Carsons S. A review and update of Sjogren's syndrome: manifestations, diagnosis and treatment. Am J Manag Care. 2001;7(suppl 14):S433-S443. Abstract

47. Brennan MT, Sankar V, Leakan RA, at al. Risk factors for positive minor salivary gland biopsy findings in Sjogren's syndrome and dry mouth patients. Arthritis Rheum. 2002;47:189-195. Abstract

48. Leuchten N, Hoyer A, Brinks R, et al. Performance of antinuclear antibodies for classifying systemic lupus erythematosus: A systematic literature review and meta-regression of diagnostic data. Arthritis Care Res (Hoboken). 2018 Mar;70(3):428-38.Full text  Abstract

49. American College of Rheumatology and HOC committee on systemic lupus erythematosus guidelines. Guidelines for the referral and management of systemic lupus erythematosus in adults. Arthritis Rheum. 1999;42:1785-1796. Abstract

50. Falk RH, Comenzo RL, Skinner M. Review article: medical progress. The systemic amyloidoses. N Eng J Med. 1997;337:898-909. Abstract

51. Mead P, Petersen J, Hinckley A. Updated CDC recommendation for serologic diagnosis of Lyme disease. MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):703.Full text  Abstract

52. Kumar N, Gross JB Jr, Ahlskog JE: Myelopathy due to copper deficiency. Neurology. 2003;61:273-274. Abstract

53. Sun A. Lysosomal storage disease overview. Ann Transl Med. 2018 Dec;6(24):476.Full text  Abstract

54. Brady RO, Schiffmann R. Clinical features of and recent advances in therapy for Fabry Disease. JAMA. 2000;284:2771-2775. Abstract

55. Eng CM, Germain DP, Banikazemi M, et al. Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. Genet Med. 2006 Sep;8(9):539-48.Full text  Abstract

56. Wierzbicki AS, Lloyd MD, Schofield CJ, Feher MD et al. Refusm disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation. J Neurochem. 2002;80:727-735. Abstract

57. Sinha S, Mahadevan A, Lokesh L, et al. Tangier disease-a diagnostic challenge in countries endemic for leprosy. J Neurol Neurosurg and Psychiatry. 2004;75:301-304.Full text  Abstract

58. Hermans G, De Jonghe B, Bruyninckx F, et al. Clinical review: critical illness polyneuropathy and myopathy. Crit Care. 2008;12:238.Full text  Abstract

59. American College of Radiology. ACR Appropriateness Criteria. Low back pain. 2015 [internet publication].Full text

Use of this content is subject to our disclaimer